Fundraising Fox

Kevin McBribe

Investor

Partner at AmorChem

Montreal

Writes $100K – $5M checks Β· typically $1.5M

About

Kevin McBribe is a General Partner and Chief Scientific Officer at AmorChem Ventures and CEO at ARNA Therapeutics. He has held positions in academic research, biotech drug discovery and development, and business development, with experience working alongside venture capital investors. He has served as a science representative at the board level for multiple organizations.

Experience

  1. TiimeCo-founder and CEOcurrent2015 β€” presentwww.tiime.org
  2. InnpactIndependent Board Directorcurrent2024 β€” present
  3. ToniicBoard Membercurrent2022 β€” present
  4. Ruth Asset ManagementIndependent Board Directorcurrent2024 β€” present
  5. Luxembourg Earth Investment Fund (LEIF)Independent Board Directorcurrent2022 β€” present
  6. Heading for ChangeGlobal Stewardship Councilcurrent2023 β€” present
  7. Criterion InstituteShift Narratives in Innovative Finance Advisory Boardcurrent2023 β€” present
  8. EQT GroupImpact Advisorcurrent2021 β€” present
  9. EQT GroupImpact Director, Mission Board to the EQT Future Fund2021 β€” 2025
  10. Ananda Impact VenturesVenture Partnercurrent2020 β€” presentMunich
  11. Regeneration GroupBoard Membercurrent2020 β€” present
  12. INSEADAdjunct Professorcurrent2019 β€” present
  13. University of LuxembourgAdjunct Professor and Guest Lecturer (Wealth Management and SESI)current2012 β€” present
  14. Luxembourg Sustainable Finance InitiativeVice Chair IIAB (Impact Investing Advisory Board)current2021 β€” presentLuxembourg
  15. Mobius Capital PartnersBoard Member (Independent Director)2018 β€” 2025
  16. Proxy PBoard Member2021 β€” 2024
  17. Subnational Climate Finance initiative (SCF)Independent Board Director2021 β€” 2023USA/Luxembourg
  18. GenderSmartAdvisory Council2017 β€” 2022London, England, United Kingdom
  19. Conseil Superieur pour un Development Durable (CSDD)Advisor to the Luxembourg Government on Sustainable Development2016 β€” 2022Luxembourg
  20. Sacred Heart University Luxembourg, Jack Welch College of BusinessAdjunct Professor of Entrepreneurship & Social Entrepreneurship / Impact Economy2006 β€” 2022
  21. University of EssexExecutive Fellow2014 β€” 2021https://www.essex.ac.uk/ebs/business/executive-fellows/

Skills & more

Strategy99Strategic Planning34Management82Negotiation33Public Speaking5ModeratingTraining6Management Consulting42Entrepreneurship99Start-ups99Business Development84Business Strategy73
+12 moreChange ManagementMergers & AcquisitionsSocial EntrepreneurshipProject ManagementProgram ManagementInvestmentsMarketingBusiness PlanningPublic RelationsBusiness AnalysisVenture CapitalInternational Business

Languages French Β· German Β· Swedish

From Kevin's professional profile.

Colleagues at AmorChem

Frequently asked questions

Who is Kevin McBribe?
Kevin McBribe is a General Partner and Chief Scientific Officer at AmorChem Ventures and CEO at ARNA Therapeutics. He has held positions in academic research, biotech drug discovery and development, and business development, with experience working alongside venture capital investors. He has served as a science representative at the board level for multiple organizations.
Where does Kevin McBribe work?
Kevin McBribe is Partner at AmorChem.
What check size does Kevin McBribe write?
Kevin McBribe typically writes checks of $100K – $5M.
Where did Kevin McBribe go to school?
Kevin McBribe studied at Brown University (BA, International Relations); Copenhagen Business School (MBA); Lund University (Masters, Political Science & Economics - focus Asia).

Same school

Shared employers